Disopyramide and its N-monodesalkyl metabolite in breast milk.
Open Access
- 1 August 1982
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 14 (2) , 310-312
- https://doi.org/10.1111/j.1365-2125.1982.tb01985.x
Abstract
The plasma and breast milk were sampled from a woman who was breastfeeding whilst taking disopyramide (200 mg three times daily). Paired samples taken on the fifth to eighth day of treatment showed that disopyramide was present in breast milk in a similar concentration to plasma (mean +/- s.d. milk; plasma ratio 0.9 +/- 0.17). The estimated dose likely to be ingested by an infant is less than 2 mg kg- 1 day-1. The active N-monodesalkyl metabolite of disopyramide (NMD) although present in plasma in much smaller concentrations than the parent compound, was excreted in breast milk (mean +/- s.d. milk: plasma ratio 5.6 +/2.9) in concentrations similar to those of disopyramide. The pharmacological and toxicological properties of the disopyramide metabolite need to be considered when assessing likely effects on the infant. No adverse effects were noted in the infant in this case. Maternal plasma and breast milk were sampled again along with infant plasma after 28 days. Disopyramide and NMD were undetectable in the infant's serum. No evidence was found to indicate that the concentrations of disopyramide or NMD in breast milk might be sufficient to pose a definite risk to the infant. Whenever disopyramide is prescribed in a breast feeding mother, close observation of the baby and measurement of both disopyramide and its active metabolite NMD in breast milk or infant plasma is recommended, pending further investigation.This publication has 9 references indexed in Scilit:
- Nadolol in human serum and breast milk.British Journal of Clinical Pharmacology, 1981
- Mexiletine in human blood and breast milkPostgraduate Medical Journal, 1981
- Accumulation of atenolol and metoprolol in human breast milkEuropean Journal of Clinical Pharmacology, 1981
- Paediatric use of mexiletine and disopyramide.BMJ, 1979
- Propranolol in human plasma and breast milkThe American Journal of Cardiology, 1979
- Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite.Clinical Chemistry, 1979
- Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscleEuropean Journal of Pharmacology, 1978
- PLACENTAL AND MILK TRANSFER OF DISOPYRAMIDE AND METABOLITES1978